StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Wednesday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
NYSE:CPHI opened at $0.23 on Wednesday. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The business’s 50-day moving average price is $0.21 and its two-hundred day moving average price is $0.22. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.64.
About China Pharma
Further Reading
- Five stocks we like better than China Pharma
- Investing in the High PE Growth Stocks
- Work and Play: Investing in the Rise of Bleisure Travel
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- 3 Grocery Stocks That Are Proving They Are Still Essential
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
